Benitez, Pacita M.

HRN: 26-96-38  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/30/2025
06/19/2025
IV
2.5g
Q8
Iopsoas Abscess, Bilateral
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: